Skip to main content
Premium Trial:

Request an Annual Quote

Indian Bioinformatics Company Questar to Make Equity Investment, Partner with AlphaGene

NEW YORK, June 18 - AlphaGene has partnered with Indian bioinformatics company Questar to mine its protein database, the companies said Monday.

In the collaboration, Questar, of Ameerpet, Hyderabad will make an equity investment in Woburn, Mass.-based AlphaGene. 

Financial terms of the deal were not disclosed. 

Questar will provide bioinformatics to aid AlphaGene in determining protein structure, pathway identification and creation of a library of potential small molecule ligands for selected putative proteins, the company said. Questar will also build standardization across AlphaGene databases.

"In completing this collaboration, Questar has signaled its desire to build intellectual property in downstream therapeutic projects with significant market potential," C.S.N. Murthy, CEO of Questar, said in a statement. "We are delighted to have the opportunity to collaborate with AlphaGene and thereby create a platform for our activities in the United States."

AlphaGene is a privately held genomics that focuses on differential gene expression in degenerative neurological diseases such as Parkinson's and Alzheimer's.   

Questar uses bioinformatics to carry out molecular-based research into diabetes, cancer, neurological disorders, and cardiovascular diseases.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.